C2 was characterized by a higher tumor mutational burden and arm-level CNAs than the other subtypes (Figs. S14, S15), corresponding to the previously described GATA3-PTCL subtype (Figs. S16, S17, and S18) [26, 36]. Here, GATA3 is linked to neoplasm.